These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 792849)

  • 21. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine.
    Veremis SA; Maddux MS; Pollak R; Kline SS; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment with antilymphocyte globulin (ALG) and evolution of renal transplant: observations of 42 cases].
    Civati G; Grillo C; Di Belgioioso GB; Rovati C; Surian M; Busnach G; Broggi L; Ferrari L
    Boll Ist Sieroter Milan; 1978 May; 57(2):165-72. PubMed ID: 365193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
    Halloran PF; Aprile MA; Farewell V; Ludwin D; Smith EK; Tsai SY; Bear RA; Cole EH; Fenton SS; Cattran DC
    Transplantation; 1988 Aug; 46(2):223-8. PubMed ID: 3043779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trial of rabbit antihuman ALG in cadaver kidney transplantation.
    Davis RC; Glasgow AH; Williams LF; Nabseth DC; Olsson CA; Schmitt GW; Idelson BA; Cooperband SR; Harrington JT; Mannick JA
    Transplant Proc; 1971 Mar; 3(1):766-8. PubMed ID: 4937970
    [No Abstract]   [Full Text] [Related]  

  • 26. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human gamma globulin enhances the survival of renal allografts.
    Riggio RR; Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Haschmeyer RH; Stenzel KH; Rubin AL
    Proc Eur Dial Transplant Assoc; 1979; 16():426-30. PubMed ID: 95048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single center experience of the effect of delayed function on outcome in retransplant recipients of cadaveric renal allografts.
    Langley J; Vergne-Marini P; Dickerman RM; Brinker KR; Land G
    Transplant Proc; 1991 Apr; 23(2):1757-9. PubMed ID: 2053145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
    Cecka JM; Terasaki PI
    Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
    Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
    Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
    Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR
    Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
    Venkat KK; Kupin W; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
    [No Abstract]   [Full Text] [Related]  

  • 34. Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups?
    Cecka JM; Gjertson D; Terasaki PI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):548-9. PubMed ID: 8438408
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal transplant survival, the HL-A system, and antilymphocyte serum therapy: report of some data collected for a recent conference.
    Corry RJ
    Transplant Proc; 1972 Sep; 4(3):401-5. PubMed ID: 4562766
    [No Abstract]   [Full Text] [Related]  

  • 36. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of sensitization to horse antilymphocyte/thymocyte globulin with recipient age and decreased renal allograft survival rates.
    Filo RS; Book B; Pescovitz MD; Milgrom ML; Leapman SB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):577-80. PubMed ID: 8438421
    [No Abstract]   [Full Text] [Related]  

  • 38. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute rejection episodes after renal transplantation in children.
    Hoyer PF; Offner G; Brodehl J
    Clin Nephrol; 1983 Feb; 19(2):61-6. PubMed ID: 6340876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG).
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.